Aquestive Therapeutics, Inc. (AQST) vs BlossomHill Therapeutics, Inc. (BLSM)
A side-by-side comparison of Aquestive Therapeutics, Inc. and BlossomHill Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AQST
Aquestive Therapeutics, Inc.
$4.58HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
BLSM
BlossomHill Therapeutics, Inc.
$18.25HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
Total return — AQST vs BLSM
growth of $100 · dividends reinvested · last 1yAQST +22.2% (+22.2%/yr)BLSM +24.6% (+24.6%/yr)BLSM compounded faster over this window
AQST BLSM
AQST vs BLSM: by the numbers
- •AQST is the larger company ($574M vs $531M market cap).
- •Both run net losses; BLSM's is the smaller (0.00% vs -144.63% net margin).
Metrics side by side
Valuation
| Metric | AQST | BLSM |
|---|---|---|
| P/S ratio | 10.61 | N/A |
Profitability
| Metric | AQST | BLSM |
|---|---|---|
| Gross margin | 67.04% | 0.00% |
| Operating margin | -156.36% | 0.00% |
| Net margin | -144.63% | 0.00% |
| ROIC | -45.62% | -43.41% |
Growth (annualized)
| Metric | AQST | BLSM |
|---|---|---|
| Revenue CAGR (5Y) | -0.58% | N/A |
| Total return CAGR (5Y) | 2.24% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.